CAMBRIDGE, Mass. (January 5, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, the Company’s chief executive officer, and David Henry, chief financial officer, will present at the H.C. Wainwright Virtual BioConnect 2021 Conference being held January 11-14, 2021. The presentation can be accessed at the following link and on the Investor Relations section of the Myomo website beginning on January 11, 2021 at 6:00 a.m. Eastern time and will be archived for 90 days. Read more.